2020 ASCO Virtual Direct™ Highlights

 

Skin
07:47

2020 ASCO Virtual Direct™ Highlights

2020 ASCO Update on Advanced Melanoma: Does Triplet Regimen Improve PFS in BRAF V600E/K Disease?

FEATURING Adil Daud
  • 169 views
  • August 6, 2020
  • 1
07:25

2020 ASCO Virtual Direct™ Highlights

2020 ASCO Update on Melanoma: Is There a Significant Antitumor Activity for Low-dose Ipilimumab + Pembrolizumab Immediately Following Progression on PD-1 Ab?

FEATURING Adil Daud
  • 37 views
  • August 24, 2020
09:06

2020 ASCO Virtual Direct™ Highlights

2020 ASCO Long-term Follow Up on TILs in Metastatic Melanoma: Is Lifileucel Effective in Refractory Disease?

FEATURING Adil Daud
  • 75 views
  • August 24, 2020
07:41

2020 ASCO Virtual Direct™ Highlights

2020 ASCO Update on IO in Metastatic Melanoma: Is the Addition of Ipilimumab to anti- PD-1 Beneficial in Patients Resistant to PD-1 Monotherapy?

FEATURING Adil Daud
  • 51 views
  • August 6, 2020